cas 29329 71 3

Chemical Abstracts Service (CAS) number 29329-71-3 corresponds to a compound known as N-[(2S)-2-Amino-3-methylbutanoyl]-L-cysteinyl-L-methionine disulfide, often more simply referred to as methionylcysteinylmethionine disulfide. This compound, while not widely recognized in everyday consumer products, holds significant potential in the realm of biochemistry and pharmaceutical development.

Methionylcysteinylmethionine disulfide is a tripeptide featuring sulfur-containing amino acids, providing unique chemical properties beneficial for certain applications. Its composition includes methionine and cysteine residues, known for their roles in biological systems where redox reactions occur. These ammonia acids are critical for antioxidant activities and can potentially aid in reducing oxidative stress, an imbalance linked to numerous chronic illnesses and aging processes. From an experience perspective, laboratories focusing on peptide-based drug delivery or antioxidant therapies hold methionylcysteinylmethionine disulfide in high regard. This compound's peptide structure allows it to serve as a model system for studying peptide interactions and disulfide bond formation, both crucial in stabilizing protein structures and influencing biological activity.

Its expertise value comes from its application in experimental pharmacology where it may be used to modulate oxidative pathways. Researchers with expertise in organic chemistry and pharmacology may employ this compound in the synthesis of more complex molecules or in the development of novel therapeutic agents aimed at mitigating oxidative stress or improving cellular repair mechanisms. The authority of methionylcysteinylmethionine disulfide in research is bolstered by publications and studies exploring its potential applications. Academic journals document its chemical interactions and pathways, offering valuable insights for further exploration. It's notable that research institutions and pharmaceutical firms could leverage this information to expand potential medicinal uses.cas 29329 71 3
Trustworthiness in handling this compound is achieved by adhering to rigorous research standards and protocols. Laboratories must ensure precise documentation of experiments and results, complying with industry regulations that govern biological testing substances. This is vital for maintaining the integrity of research carried out with methionylcysteinylmethionine disulfide. In the pharmaceutical context, methionylcysteinylmethionine disulfide could be investigated for its role in enhancing drug stability or bioavailability. Its antioxidant properties might be tapped in the formulation of supplements or medicinal compounds aiming to protect cells from damage or enhance longevity. Despite its potential, methionylcysteinylmethionine disulfide requires further study to fully understand its capabilities and limitations within applied settings. Cooperation among chemists, pharmacologists, and other scientific disciplines will be crucial in unlocking the full range of possibilities offered by this fascinating compound. In conclusion, methionylcysteinylmethionine disulfide, identified by CAS number 29329-71-3, stands out in research focused on peptides and oxidative processes. Its future in biochemical research and potential applications in pharmacology highlight its value across multiple domains, thus affirming its importance as a compound of interest in advancing chemical and medical sciences.